| Literature DB >> 30380110 |
Nupur N Uppal1, Divya Monga2, Melchiore A Vernace3, Khurram Mehtabdin1, Hitesh H Shah1, Vanesa Bijol4, Kenar D Jhaveri1.
Abstract
Waldenström macroglobulinemia (WM) is a rare B-cell lymphoma characterized by lymphoplasmacytic cell infiltration in the bone marrow and other organs and the presence of a monoclonal immunoglobulin M protein in the serum. Although uncommon, several kidney diseases have been associated with WM. In addition to kidney diseases related to lymphoplasmacytic lymphoma infiltration, a variety of glomerular and tubular lesions have been described in patients with WM. Immunoglobulin light chain (AL) amyloidosis and cryoglobulinemic glomerulonephritis are the two predominant glomerular pathologies seen in WM. In this article we review the kidney diseases associated with WM. We also briefly review some nephrotoxicities of novel chemotherapeutic and targeted therapies used for the treatment of WM.Entities:
Keywords: MPGN; Waldenström macroglobulinemia; amyloidosis; onconephrology; paraproteinemia
Mesh:
Year: 2019 PMID: 30380110 DOI: 10.1093/ndt/gfy320
Source DB: PubMed Journal: Nephrol Dial Transplant ISSN: 0931-0509 Impact factor: 5.992